Steven Cohen Vertex Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $54.5 Million - $58.4 Million
-161,025 Reduced 65.34%
85,414 $29.7 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $3.79 Million - $4.24 Million
-12,061 Reduced 4.67%
246,439 $86.7 Million
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $41.8 Million - $47.7 Million
147,661 Added 133.22%
258,500 $81.4 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $982,728 - $1.11 Million
3,439 Added 3.2%
110,839 $32 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $29.4 Million - $32.8 Million
107,400 New
107,400 $31.1 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $10.5 Million - $12.4 Million
-47,600 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $8.43 Million - $10.6 Million
47,600 New
47,600 $10.5 Million
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $12.1 Million - $13.5 Million
-66,500 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $112 Million - $132 Million
-597,473 Reduced 89.98%
66,500 $13.4 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $91.3 Million - $106 Million
440,873 Added 197.61%
663,973 $143 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $19.2 Million - $25.6 Million
92,900 Added 71.35%
223,100 $52.7 Million
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $33.3 Million - $39.5 Million
130,200 New
130,200 $35.4 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $22.9 Million - $28.5 Million
-114,821 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $13.4 Million - $18 Million
-80,490 Reduced 41.21%
114,821 $25.1 Million
Q3 2019

Nov 15, 2019
BUY
$166.23 - $187.09 $13 Million - $14.6 Million
77,939 Added 66.4%
195,311 $33.1 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $1.1 Million - $1.27 Million
6,654 Added 6.01%
117,372 $21.5 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $6.96 Million - $8.28 Million
42,518 Added 62.34%
110,718 $20.4 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $5.27 Million - $6.67 Million
-34,700 Reduced 33.72%
68,200 $11.3 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $40.6 Million - $46.6 Million
-241,915 Reduced 70.16%
102,900 $19.8 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $45.9 Million - $53.5 Million
314,815 Added 1049.38%
344,815 $58.6 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $103 Million - $120 Million
-679,817 Reduced 95.77%
30,000 $4.89 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $27.4 Million - $31 Million
-199,413 Reduced 21.93%
709,817 $106 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $135 Million - $148 Million
909,230
909,230 $138 Million

Others Institutions Holding VRTX

# of Institutions
1,726
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email